Harald Hugenschmidt

1.0k total citations
13 papers, 826 citations indexed

About

Harald Hugenschmidt is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Harald Hugenschmidt has authored 13 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Harald Hugenschmidt's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Cells and Metastasis (5 papers) and Cancer Genomics and Diagnostics (4 papers). Harald Hugenschmidt is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Cells and Metastasis (5 papers) and Cancer Genomics and Diagnostics (4 papers). Harald Hugenschmidt collaborates with scholars based in Norway, Germany and United States. Harald Hugenschmidt's co-authors include Clemens Unger, Dieter Marmé, Christine Wittig, Joachim Drevs, H. Madjar, Ilse Hofmann, Georg Martiny‐Baron, J M Wood, Knut Jørgen Labori and Gro Wiedswang and has published in prestigious journals such as The Journal of Immunology, Annals of Surgery and European Urology.

In The Last Decade

Harald Hugenschmidt

13 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harald Hugenschmidt Norway	11	417	384	267	189	107	13	826
Andrea Fontana Italy	19	549 1.3×	285 0.7×	238 0.9×	335 1.8×	100 0.9×	50	1.0k
Enzo Mammano Italy	18	414 1.0×	470 1.2×	203 0.8×	173 0.9×	82 0.8×	31	1.0k
Yozo Kawano Japan	19	435 1.0×	657 1.7×	362 1.4×	331 1.8×	124 1.2×	28	1.2k
Maudy Walraven Netherlands	5	287 0.7×	326 0.8×	295 1.1×	179 0.9×	42 0.4×	8	649
Gerrit K. Hooijer Netherlands	15	565 1.4×	261 0.7×	298 1.1×	169 0.9×	97 0.9×	34	889
Bonne J. Adams United States	11	469 1.1×	387 1.0×	273 1.0×	264 1.4×	47 0.4×	26	824
P. Vermeulen Belgium	13	537 1.3×	582 1.5×	419 1.6×	210 1.1×	48 0.4×	22	1.0k
Tetsuji Sawada Japan	20	392 0.9×	494 1.3×	199 0.7×	138 0.7×	220 2.1×	38	928
Analía Azaro Spain	18	557 1.3×	569 1.5×	198 0.7×	295 1.6×	152 1.4×	56	1.1k
Jeroen Dekervel Belgium	18	617 1.5×	316 0.8×	230 0.9×	165 0.9×	112 1.0×	69	1.1k

Countries citing papers authored by Harald Hugenschmidt

Since Specialization

Citations

This map shows the geographic impact of Harald Hugenschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Hugenschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Hugenschmidt more than expected).

Fields of papers citing papers by Harald Hugenschmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Hugenschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Hugenschmidt. The network helps show where Harald Hugenschmidt may publish in the future.

Co-authorship network of co-authors of Harald Hugenschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Hugenschmidt. A scholar is included among the top collaborators of Harald Hugenschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Hugenschmidt. Harald Hugenschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hugenschmidt, Harald, Knut Jørgen Labori, Elin Borgen, et al.. (2021). Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer. Cancers. 13(3). 485–485. 30 indexed citations

Hugenschmidt, Harald, Knut Jørgen Labori, Cathrine Brunborg, et al.. (2020). Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information. BMC Cancer. 20(1). 1107–1107. 4 indexed citations

Hugenschmidt, Harald, Knut Jørgen Labori, Cathrine Brunborg, et al.. (2018). Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma. Annals of Surgery. 271(3). 549–558. 43 indexed citations

Brunborg, Cathrine, Anne Waage, Harald Hugenschmidt, et al.. (2017). Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases. Annals of Surgical Oncology. 24(8). 2113–2121. 18 indexed citations

Hugenschmidt, Harald, Morten Hagness, Espen Melum, et al.. (2017). CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer. The Journal of Immunology. 198(4). 1729–1739. 24 indexed citations

Brudvik, Kristoffer W., Harald Hugenschmidt, Anne Renolen, et al.. (2015). Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases. Annals of Surgical Oncology. 22(12). 4029–4037. 9 indexed citations

Hugenschmidt, Harald, Morten Hagness, Pål‐Dag Line, et al.. (2015). Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer. OncoImmunology. 5(4). e1102828–e1102828. 55 indexed citations

Waage, Anne, Cathrine Brunborg, Harald Hugenschmidt, et al.. (2014). Circulating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired Survival. Annals of Surgery. 261(1). 164–171. 46 indexed citations

Hugenschmidt, Harald, et al.. (2013). Follow-up after curative surgery for pancreatic ductal adenocarcinoma: Asymptomatic recurrence is associated with improved survival. European Journal of Surgical Oncology. 39(6). 559–566. 39 indexed citations

10.

Grimm, Marc‐Oliver, et al.. (2002). Clinical Outcome of Patients with Lymph Node Positive Prostate Cancer after Radical Prostatectomy versus Androgen Deprivation. European Urology. 41(6). 628–634. 47 indexed citations

11.

Drevs, Joachim, Christine Wittig, Stefan Fuxius, et al.. (2002). PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.. PubMed. 62(14). 4015–22. 181 indexed citations

12.

Drevs, Joachim, Ilse Hofmann, Harald Hugenschmidt, et al.. (2000). Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.. PubMed. 60(17). 4819–24. 257 indexed citations

13.

Hugenschmidt, Harald, et al.. (1998). Urinary levels of monocyte chemo‐attractant protein‐1 correlate with tumour stage and grade in patients with bladder cancer. British Journal of Urology. 82(1). 118–121. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact